Adjuvant treatment in patients at high risk of recurrence of thymoma: efficacy and safety of a three-dimensional conformal radiation therapy regimen
CNR Ibb | back to homepage
CNR Ibb | back to homepage

Adjuvant treatment in patients at high risk of recurrence of thymoma: efficacy and safety of a three-dimensional conformal radiation therapy regimen (321 views)

Perri F, Pisconti S, Conson M, Pacelli R, Della Vittoria Scarpati G, Gnoni A, D'Aniello C, Cavaliere C, Licchetta A, Cella L, Giuliano M, Schiavone C, Falivene S, Di Lorenzo G, Buonerba C, Ravo V, Muto P

Oncotargets Ther (ISSN: 1178-6930, 1178-6930linking), 2015 Jun 8; 8: 1345-1349.

Export to BibTeX    Export to EndNote

Paper type: Journal Article,

Impact factor: 2.272, 5-year impact factor: 2.235

Url: http://www.scopus.com/inward/record.url?eid=2-s2.0-84934343729&partnerID=40&md5=dc655fe2ce94fbebb53e050613680136

Keywords: Adjuvant Treatment, Local Control, Three-Dimensional Conformal Radiotherapy, Thymoma, Toxicity,

Affiliations:
*** IBB - CNR ***

Medical Oncology Unit, POC S Annunziata, Taranto, Italy
Department of Advanced Biomedical Sciences, University of Naples Federico II, Naples, Italy
Institute of Biostructures and Bioimaging, National Council of Research, Naples, Italy
Department of Clinical Medicine and Surgery, University of Naples Federico II, Naples, Italy
Lester and Sue Smith Breast Center, Baylor College of Medicine, Houston, TX, United States
Division of Oncology, Centro di riferimento Oncologico di Basilicata, IRCCS Rionero in Vulture, Potenza, Italy
Department of Radiotherapy, Istituto Nazionale per la Cura dei Tumori-Fondazione G. Pascale. IRCCS di Napoli, Naples, Italy
Commonwealth Scientific \& Industrial Research Organisation (CSIRO)
Consiglio Nazionale delle Ricerche (CNR)
Fdn G Pascale IRCCS Napoli


References:
Not available.
Adjuvant treatment in patients at high risk of recurrence of thymoma: efficacy and safety of a three-dimensional conformal radiation therapy regimen

Background: The clinical benefits of postoperative radiation therapy (PORT) for patients with thymoma are still controversial. In the absence of defined guidelines, prognostic factors such as stage, status of surgical margins, and histology are often considered to guide the choice of adjuvant treatment (radiotherapy and/or chemotherapy). In this study, we describe our single-institution experience of three-dimensional conformal PORT administered as adjuvant treatment to patients with thymoma. Methods: Twenty-two consecutive thymoma patients (eleven male and eleven female) with a median age of 52 years and treated at our institution by PORT were analyzed. The patients were considered at high risk of recurrence, having at least one of the following features: stage IIB or III, involved resection margins, or thymic carcinoma histology. Three-dimensional conformal PORT with a median total dose on clinical target volume of 50 (range 44–60) Gy was delivered to the tumor bed by 6–20 MV X-ray of the linear accelerator. Follow-up after radiotherapy was done by computed tomography scan every 6 months for 2 years and yearly thereafter. Results: Two of the 22 patients developed local recurrence and four developed distant metastases. Median overall survival was 100 months, and the 3-year and 5-year survival rates were 83% and 74%, respectively. Median disease-free survival was 90 months, and the 5-year recurrence rate was 32%. On univariate analysis, pathologic stage III and presence of positive surgical margins had a significant impact on patient prognosis. Radiation toxicity was mild in most patients and no severe toxicity was registered. Conclusion: Adjuvant radiotherapy achieved good local control and showed an acceptable toxicity profile in patients with high-risk thymoma. © 2015, Perri et al.
Adjuvant treatment in patients at high risk of recurrence of thymoma: efficacy and safety of a three-dimensional conformal radiation therapy regimen

No results.
Adjuvant treatment in patients at high risk of recurrence of thymoma: efficacy and safety of a three-dimensional conformal radiation therapy regimen

Filter those results▼
Query:  [X]
Options:
   Extended  
   IBB affiliation
 
Authors:  [X]
Paper type:  [X]
Start date:  [X]
End date:  [X]
Site:
[Clear form]
Select the year: 
Other filter: ([btitle,keywords] "Adjuvant Treatment" ...

Sort by:   date ▼▲   title ▲ ▼   journal ▲ ▼   authors ▲ ▼   I.F. ▲ ▼
Perri F, Addeo R, Conson M, Faiella A, Scarpati GDV, Torre G, Di Biase A, Romanelli P, Buonerba C, Di Lorenzo G, Daponte A, Caponigro F, Pisconti S, Pacelli R, Ravo V, Muto P, Solla R
* Locally advanced paranasal sinus carcinoma: A study of 30 patients (311 views)
Oncol Lett (ISSN: 1792-1074), 2017 Mar; 13(3): 1338-1342.
Impact Factor: 1.664
View    Export to BibTeX    Export to EndNote

Conson M, Faiella A, Iorio V, Cella L, Liuzzi R, Solla R, Romanelli P, Farella A, Salvatore M, Pacelli R
* Her-2 Subtype And Age Affect Local Control In Breast Cancer (435 views)
Radiother Oncol (ISSN: 0167-8140, 1879-0887, 1879-0887electronic), 2013; 106: N/D-N/D.
Impact Factor: 4.857
View    Export to BibTeX    Export to EndNote

Carlomagno C, Farella A, Bucci L, D'Armiento FP, Pesce G, Pepe S, Cannella L, Pacelli R, De Stefano A, Solla R, D'Armiento MR, De Placido S
* Neo-adjuvant treatment of rectal cancer with capecitabine and oxaliplatin in combination with radiotherapy: A phase II study (855 views)
Annals Of Oncology (ISSN: 0923-7534), 2009 May; 20(5): 906-912.
Impact Factor: 5.647
View    Export to BibTeX    Export to EndNote

3 Records (2 excluding Abstracts).
Total impact factor: 12.168 (7.311 excluding Abstracts).
Total 5 year impact factor: 11.7 (7.03 excluding Abstracts).

Last modified by Marco Comerci on Sunday 12 July 2020, 13:14:49
321 views. Last view on Thursday 26 September 2024, 11:30:36